Skip to main content

Immatics N.V.

IMTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001809196

In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Immatics N.V. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of IMTX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders8482−2
Shares108.2M99.8M−8.39M (−7.8%)
Value$1.06B$1.01B−$53.6M (−5.0%)

New holders (11)

Institutions that held Immatics N.V. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to IMTX in Q2 2026
InstitutionSharesValue% of portfolio
Boxer Capital Management, LLC475,000$4.81M0.36%
Moore Capital Management, LP192,770$1.95M0.04%
D. E. Shaw & Co., Inc.59,161$599.3K0.00%
Macquarie Group Ltd53,500$542.0K0.00%
HRT Financial LP31,724$321.0K0.00%
Brandywine Managers, LLC25,227$255.6K0.13%
Quadrature Capital Ltd14,726$149.2K0.00%
Susquehanna International Group, LLP11,469$116.2K0.00%
State of Wyoming10,791$109.3K0.01%
Verdad Advisers, LP10,483$106.2K0.10%
Royal Bank of Canada1,110$11.0K0.00%

Sold out (13)

Institutions that held Immatics N.V. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of IMTX in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Toronto Dominion Bank7,436,342$73.2M
Longaeva Partners L.P.780,967$7.68M
Troluce Capital Advisors LLC250,000$2.46M
Y-Intercept (Hong Kong) Ltd75,427$742.2K
Robeco Institutional Asset Management B.V.24,034$236.5K
Boothbay Fund Management, LLC21,094$207.6K
Pale Fire Capital SE16,272$160.1K
Simplex Trading, LLC4,891$48.1K
Wells Fargo & Company464$4.57K
Quantbot Technologies LP191$1.88K
GWM Advisors LLC100$984
Parallel Advisors, LLC52$512
Clearstead Advisors, LLC25$244